Business ❯Healthcare ❯Pharmaceuticals

Weight Loss Drugs

Novo Nordisk Zepbound Eli Lilly Eli Lilly Zepbound Mounjaro and Zepbound Wegovy GLP-1 Medications Market Competition Compounded Drugs Viking Therapeutics Roche Compounded Semaglutide

Domino's Faces Mixed Earnings Report with U.S. Sales Lagging Expectations

Allurion Technologies Stock Surges Following New Obesity Treatment Study Announcement

Novo Nordisk Expands Wegovy Supply Amid Compounding Drug Concerns

Roche Accelerates Development of Promising Weight-Loss Pills

Viking Therapeutics Advances Weight-Loss Drug, Shaking Up Market Leaders